Projects funded by the NCN
The role of insulin signaling in melanoma maintenance and response to targeted therapeutics
2017/25/N/NZ3/02042
Keywords:
melanoma insulin targeted therapy
Descriptors:
- NZ3_1: Cell biology
- NZ1_1: Molecular biology
Panel:
NZ3 - Cellular and developmental biology: cell biology, developmental biology, ageing biology, neurobiology
Host institution :
Uniwersytet Medyczny w Łodzi, Wydział Lekarski
woj. łódzkie
Principal investigator (from the host institution):
Number of co-investigators in the project: 2
Call: PRELUDIUM 13 - announced on 2017-03-15
Amount awarded: 120 000 PLN
Project start date (Y-m-d): 2018-03-22
Project end date (Y-m-d): 2020-06-21
Project duration:: 27 months (the same as in the proposal)
Project status: Project settled
Project description
Download the project description in a pdf file
Note - project descriptions were prepared by the authors of the applications themselves and placed in the system in an unchanged form.
Information in the final report
- Publication in academic press/journals (1)
- Insulin Reduces the Efficacy of Vemurafenib and Trametinib in Melanoma CellsAuthors:Marta Osrodek, Michal Rozanski, Malgorzata CzyzAcademic press:Cancer Management and Research (rok: 2020, tom: 84,1805555555556, strony: 7231-7250), Wydawca: Dove Medical PressStatus:PublishedDOI:10.2147/CMAR.S263767 - link to the publication